BHC
REGN icon

Bull Harbor Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bull Harbor Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$994K Sell
1,594
-472
-23% -$321K 0.19% 159
2026
Q1 		$1.6M Buy
+2,066
New +$1.58M 0.43% 50

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bull Harbor Capital's REGN Position: Q2 2026 in Review

Bull Harbor Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 23% in Q2 2026, selling an estimated $321K and leaving 1,594 shares worth $994K. The position accounts for 0.19% of the portfolio, ranked #159.

Bull Harbor Capital first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.6M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Bull Harbor Capital held 1,594 shares of Regeneron Pharmaceuticals worth $994K as of Q2 2026.
  • Bull Harbor Capital sold 472 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $321K.
  • Regeneron Pharmaceuticals made up 0.19% of Bull Harbor Capital's portfolio in Q2 2026, its #159 holding.
  • Bull Harbor Capital first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Bull Harbor Capital's Regeneron Pharmaceuticals position peaked at $1.6M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bull Harbor Capital's 13F filing for Q2 2026, filed 10 Aug 2026.